PUBBLICAZIONI CLINICA METABOLICA
Pubblicazioni 2020
Le seguenti pubblicazioni sono state pubblicate nel corso dell’anno 2020
Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV.
Milic J, Menozzi V, Schepis F, Malagoli A, Besutti G, Franconi I, Raimondi A, Carli F, Mussini C, Sebastiani G, Guaraldi G.
AIDS. 2020 Nov 1;34(13):1915-1921. doi: 10.1097/QAD.0000000000002650.
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0.
Ryom L, Cotter A, De Miguel R, Béguelin C, Podlekareva D, Arribas JR, Marzolini C, Mallon P, Rauch A, Kirk O, Molina JM, Guaraldi G, Winston A, Bhagani S, Cinque P, Kowalska JD, Collins S, Battegay M; EACS Governing Board.
HIV Med. 2020 Nov;21(10):617-624. doi: 10.1111/hiv.12878. Epub 2020 Sep 3
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV.
Adrian S, Miao H, Feng H, Scherzinger A, Nardini G, Beghetto B, Roncaglia E, Ligabue G, Milic J, Guaraldi G, Lake JE, Erlandson KM.
HIV Res Clin Pract. 2020 Aug;21(4):91-98. doi: 10.1080/25787489.2020.1809807. Epub 2020 Sep 3.
Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus Monoinfection.
Maurice JB, Goldin R, Hall A, Price JC, Sebastiani G, Morse CG, Prat LI, Perazzo H, Garvey L, Ingiliz P, Guaraldi G, Tsochatzis E, Lemoine M.
Clin Infect Dis. 2021 Oct 5;73(7):e2184-e2193. doi: 10.1093/cid/ciaa1302.
A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV.
Guaraldi G, Milic J, Marcotullio S, Mussini C.
J Antimicrob Chemother. 2020 Dec 1;75(12):3425-3432. doi: 10.1093/jac/dkaa329
Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease.
Gonzalez-Cordon A, Assoumou L, Camafort M, Domenech M, Guaraldi G, Domingo P, Rusconi S, Raffi F, Katlama C, Masia M, Bernardino JI, Saumoy M, Pozniak A, Gatell JM, Martinez E; NEAT022 Study Group.
J Antimicrob Chemother. 2020 Nov 1;75(11):3334-3343. doi: 10.1093/jac/dkaa292.
The Lisbon patient: exceptional longevity with HIV suggests healthy aging as an ultimate goal for HIV care.
Pintassilgo I, Cesari M, Santos HN, Milic J, Franconi I, Mussini C, Marques N, Guaraldi G.
BMC Infect Dis. 2020 Apr 20;20(1):290. doi: 10.1186/s12879-020-05020-8.
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus.
Cervo A, Milic J, Mazzola G, Schepis F, Petta S, Krahn T, Lebouche B, Deschenes M, Cascio A, Guaraldi G, Sebastiani G.
Clin Infect Dis. 2020 Dec 17;71(10):e694-e701. doi: 10.1093/cid/ciaa430.
Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.
Krahn T, Martel M, Sapir-Pichhadze R, Kronfli N, Falutz J, Guaraldi G, Lebouche B, Klein MB, Wong P, Deschenes M, Ghali P, Sebastiani G.
J Infect Dis. 2020 Aug 4;222(5):787-797. doi: 10.1093/infdis/jiaa170.
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients.
Guaraldi G, Milic J, Prandini N, Ligabue G, Esposito F, Ciusa G, Malagoli A, Scaglioni R, Besutti G, Beghetto B, Nardini G, Roncaglia E, Mussini C, Raggi P.
Atherosclerosis. 2020 Mar;297:127-135. doi: 10.1016/j.atherosclerosis.2020.02.014. Epub 2020 Feb 17.
New Drugs for NASH and HIV Infection: Great Expectations for a Great Need.
Guaraldi G, Maurice JB, Marzolini C, Monteith K, Milic J, Tsochatzis E, Bhagani S, Morse CG, Price JC, Ingiliz P, Lemoine M, Sebastiani G; SHIVER Network.
Hepatology. 2020 May;71(5):1831-1844. doi: 10.1002/hep.31177.
Sex Differences in People Aging With HIV.
Brañas F, Sánchez-Conde M, Carli F, Menozzi M, Raimondi A, Milic J, Franconi J, Cuomo G, Mussini C, Moreno S, Guaraldi G.
J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):284-291. doi: 10.1097/QAI.0000000000002259.
Therapeutic management of HIV-infected patients with chronic kidney disease.
Alfano G, Guaraldi G, Fontana F, Bellasi A, Cappelli G.
J Nephrol. 2020 Aug;33(4):699-713. doi: 10.1007/s40620-020-00701-8. Epub 2020 Feb 4.
Geriatric Syndromes in People Living with HIV Associated with Ageing and Increasing Comorbidities: Implications for Neurocognitive Complications of HIV Infection.
Falutz J, Kirkland S, Guaraldi G.
Curr Top Behav Neurosci. 2021;50:301-327. doi: 10.1007/7854_2019_119.
Vitamin E as a 'bridge' therapy for nonalcoholic steatohepatits in HIV: what is waiting on the other side of the bridge?
Guaraldi G, Milic J.
AIDS. 2020 Feb 1;34(2):317-319. doi: 10.1097/QAD.0000000000002413.
Implementing routine physical function screening among elderly HIV-positive patients in Uganda.
Lwanga I, Nabaggala MS, Kiragga A, Calcagno A, Guaraldi G, Lamorde M, Castelnuovo B.
AIDS Care. 2020 Nov;32(11):1467-1470. doi: 10.1080/09540121.2019.1703888. Epub 2019 Dec 17.
Aging with HIV.
Guaraldi G, Milic J, Mussini C.
Curr HIV/AIDS Rep. 2019 Dec;16(6):475-481. doi: 10.1007/s11904-019-00464-3.
Thymus Imaging Detection and Size Is Inversely Associated With Metabolic Syndrome and Frailty in People With HIV.
Guaraldi G, Franconi I, Milic J, Besutti G, Pintassilgo I, Scaglioni R, Ligabue G, Riva N, Raimondi A, Menozzi M, Carli F, Zona S, Santoro A, Malagoli A, Borghi V, Torricelli P, Cossarizza A, Mussini C.
Open Forum Infect Dis. 2019 Oct 4;6(10):ofz435. doi: 10.1093/ofid/ofz435. eCollection 2019 Oct.
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients.
Sebastiani G, Cocciolillo S, Mazzola G, Malagoli A, Falutz J, Cervo A, Petta S, Pembroke T, Ghali P, Besutti G, Franconi I, Milic J, Cascio A, Guaraldi G.
HIV Med. 2020 Feb;21(2):96-108. doi: 10.1111/hiv.12799. Epub 2019 Oct 23.
TUTTE LE NOSTRE PUBBLICAZIONI
Siamo lieti
di accoglierti
Chiedici informazioni
o prenota la tua prima visita
presso la Clinica Metabolica
di Modena